8th DIA CMC Forum in Japan

概要

This program will be conducted in Japanese Language only.

Online Registration has been closed. Onsite Registration will be available at TKP Tokyo Station Yaesu Conference Center.

Tomoaki Sakamoto, PhD Section Chief, Division of Drugs
National Institute of Health Sciences, Japan
Rie Fujita Reviewer, Office of Cellular and Tissue-based Products
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Takeshi Hamaura, PhD Head of Pharmaceutical Technology Division
Daiichi Sankyo Co., Ltd., Japan
Fusashi Ishikawa, PhD, MSc Associate Biopharmaceutics Research Fellow, Formulation R&D Laboratories
Sumitomo Dainippon Pharma Co., Ltd., Japan
Motonori Kidokoro, PhD Director, Regulatory Affairs CMC
Daiichi Sankyo Pharma Development, United States
Hitomi Koro Reviewer, Office of Cellular and Tissue-based Products
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Yoshihiro Matsuda, PhD Senior Scientist (for Quality), Pharmacist
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Yuko Nagai Manager, Regulatory Affairs Office, Quality & Pharmacovigilance Division
Nippon Kayaku Co., Ltd., Japan
Yoshio Nakayama Regulatory Scientist, CM&C Regulatory Affairs, Japan Regulatory Affairs
Eli Lilly Japan K.K., Japan
Hiroko Shibata Senior Researcher, Division of Drugs
National Institute of Health Sciences, Japan
Yutaka Takahashi Senior Manager, Pharmaceutical Planning & Control
Astellas Pharma Inc., Japan
Satomi Yagi Reviewer, Office of New Drug III
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Yukio Hiyama, PhD Visiting Researcher
National Institute of Health Sciences, Japan

Download